We demonstrated that administration of HA-PEI/HA-PEG/MDR1 siRNA CD44 targeted nanoparticle followed by paclitaxel treatment had similar effects on tumor growth as the control group of tumor treated with saline and paclitaxel in SKOV-3 xenograft model (Fig. 4D). Here, CD44 is linked to neoplasm.